European Journal of Cancer
Volume 39, Issue 17 , Page 2566, November 2003

A comment on “Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders”☆

Chemotherapy Unit at the Istituto Ortopedico Rizzoli, Bologna, Italy

Received 5 June 2003; accepted 13 June 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ European Journal of Cancer 2003, 39, 488–494. Doi of article referred to: 10.1016/S0959-8049(02)00747-5.

PII: S0959-8049(03)00546-X

doi:10.1016/S0959-8049(03)00546-X

European Journal of Cancer
Volume 39, Issue 17 , Page 2566, November 2003

Article Tools